Beyond the Scale: Investigating the Emerging Intersection of GLP-1 Agonists and Mental Health

For 39-year-old Hilary, a California resident, the struggle with depression was a lifelong companion, characterized by a cycle of failed antidepressant trials and persistent emotional heaviness. Her experience is not…

GLP-1 Receptor Agonists Show Remarkable Mental Health Benefits, Large-Scale Study Reveals

Medications commonly prescribed for type 2 diabetes and obesity, including prominent brands such as Ozempic and Wegovy, are demonstrating an unexpected and significant positive impact on mental health. A comprehensive…